CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
about
Glioblastoma formation from cell population depleted of Prominin1-expressing cellsCD133 antigen expression in ovarian cancerAnaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profileCD133 (Prominin) negative human neural stem cells are clonogenic and tripotentLong non-coding RNAs in nervous system function and diseaseCancer stem cells (CSCs), cervical CSCs and targeted therapiesCancer Stem Cell Hierarchy in Glioblastoma MultiformeGlioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic TargetsGlioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and RadioresistanceGlioblastoma Stem Cells as a New Therapeutic Target for GlioblastomaTherapies targeting cancer stem cells: Current trends and future challengesCommon stemness regulators of embryonic and cancer stem cellsTargeting Aggressive Cancer Stem Cells in GlioblastomaAutophagy and radiosensitization in cancerCancer stem cells in brain tumors and their lineage hierarchyUnderstanding glioma stem cells: rationale, clinical relevance and therapeutic strategiesDevelopmental origins of brain tumorsThe potential origin of glioblastoma initiating cellsNovel delivery strategies for glioblastomaCancer stem cells--the current status of an old concept: literature review and clinical approachesTargeting glioma stem cells: a novel framework for brain tumorsTumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progeniesCD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cellsIn silico experimentation of glioma microenvironment development and anti-tumor therapyIntracellular autofluorescence: a biomarker for epithelial cancer stem cellsCancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea AttentionPhage display discovery of novel molecular targets in glioblastoma-initiating cellsProportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cellsThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisT cells enhance stem-like properties and conditional malignancy in gliomasGSK3beta regulates differentiation and growth arrest in glioblastomaOvercoming therapeutic resistance in glioblastoma: the way forwardTumour heterogeneity and cancer cell plasticityDetection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibodyNovel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.β-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomas.A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters.Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate.Remnant living cells that escape cell loss in late-stage tumors exhibit cancer stem cell-like characteristics
P2860
Q21091187-2986E341-2DF9-455C-88DD-A669D2BDE96EQ21093306-32C76DC6-6D3B-4D31-94B8-9F6CE7D47BCFQ21245722-FE3AC97D-0796-4EFB-90A5-5CA436B88ED0Q21562426-F652E703-942B-4F6C-BDD7-9351CDE9B68FQ24595656-9044D7AE-983E-486E-A093-BE35D5DF2939Q26747144-285DC0FA-A5B3-481A-92B3-588D613659CDQ26752312-66317498-F894-487A-B95A-01A7AEE800D4Q26765758-92C7C569-9024-4B68-9F13-7888AEA32F09Q26765869-E1F1B616-701A-471D-95E7-3567A9FB986FQ26776219-E792AA18-A976-4D9C-ABCC-E069078B5682Q26777880-EE67DB26-7BDC-4E55-9122-AAD17FBB73AAQ26777882-36C73C2A-F75C-4933-AFC4-3456664809FDQ26799983-2F21E1D4-7AB2-4F83-ACEE-D81A08F05AC8Q26865330-FF59B209-3EDF-44CF-B3DF-F4CE3DF54E6DQ26992115-6414FBE5-7FE6-4ED0-9EBC-C54A854200B6Q26995698-B7F8FB96-E9D2-47B1-ABDF-0DEB638870E0Q27000677-41EA88BB-44E1-4808-973A-7E8567C6A1E9Q27005807-B49B3B70-7D07-4004-B63F-E1AA8A4164DCQ27006099-015DD4C9-48A4-4843-97DE-A3A97683D632Q27025165-56F4B1C0-27E9-425B-BFDF-72E7ECC75439Q27026818-A96F2CAF-CE17-45D5-ACEA-5BAAAD40F19DQ27318628-C5AAEB5D-FA1A-4C67-8E4B-A8C9165385C1Q27329081-1872CCF8-461B-4DAB-A4A2-2CCF2040E9FCQ27332126-85E41C87-F523-4B2B-9508-BA36350246ADQ28049473-75204DF3-B7C4-43CC-98AF-8FAA5E869C79Q28069232-D1B5BCCA-C502-4EF9-AA1E-F5D7FB115BA8Q28240138-07A78126-3F69-486B-9E02-D472E8E23C73Q28257733-192CDD9B-E9E7-4449-BBF1-DAEB6B1981F1Q28388257-9A4E9D93-A6FC-4F6A-973D-D63DAF5E6A0AQ28474262-2C6CDA92-7C65-44E0-A9C4-5BE1A685ABD3Q28476300-3BA34C61-AFD1-424F-8B10-1185677EDFD0Q29248396-B6B24CC0-12E4-4356-BD86-C8F7C81E7279Q29617990-A03019DB-141D-422D-8798-52336CA6D353Q30388310-181D4F34-AFA8-42B3-B00C-99DC25C44C46Q30413140-0D4FEDD7-20ED-4934-B733-DE051712FFADQ30424372-3DD6F022-16CF-4116-B553-92321B4219DDQ30426915-71FA6CE3-AC5F-427E-A552-979187A28E8FQ30467807-002E35AF-BF21-4046-A845-D35EEC79032CQ30525687-27F79F2C-B490-4762-82CE-A3E136F13B1CQ30526491-5137B891-C0AF-4441-8C13-04C7269BEF82
P2860
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
CD133(+) and CD133(-) glioblas ...... istics and molecular profiles.
@en
type
label
CD133(+) and CD133(-) glioblas ...... istics and molecular profiles.
@en
prefLabel
CD133(+) and CD133(-) glioblas ...... istics and molecular profiles.
@en
P2093
P50
P1433
P1476
CD133(+) and CD133(-) glioblas ...... istics and molecular profiles.
@en
P2093
Annette Lohmeier
Christoph P Beier
Dagmar Beier
Ludwig Aigner
Peter J Oefner
P304
P356
10.1158/0008-5472.CAN-06-4180
P407
P577
2007-05-01T00:00:00Z